MacroGenics, Inc.
MGNX
$4.11
-$0.21-4.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 153.62M | 127.66M | 127.98M | 106.10M | 143.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 153.62M | 127.66M | 127.98M | 106.10M | 143.97M |
| Cost of Revenue | 162.14M | 164.15M | 168.88M | 169.17M | 167.28M |
| Gross Profit | -8.52M | -36.50M | -40.90M | -63.06M | -23.31M |
| SG&A Expenses | 36.75M | 38.15M | 39.16M | 57.74M | 61.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 198.90M | 202.30M | 208.04M | 226.90M | 229.22M |
| Operating Income | -45.28M | -74.65M | -80.06M | -120.80M | -85.24M |
| Income Before Tax | -109.05M | -82.02M | -82.51M | -82.05M | -42.57M |
| Income Tax Expenses | -777.00K | -672.00K | -672.00K | 1.05M | 1.05M |
| Earnings from Continuing Operations | -108.27 | -81.35 | -81.84 | -83.10 | -43.62 |
| Earnings from Discontinued Operations | 93.68M | 10.99M | 7.22M | 7.22M | 7.22M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.59M | -70.36M | -74.62M | -75.89M | -36.40M |
| EBIT | -45.28M | -74.65M | -80.06M | -120.80M | -85.24M |
| EBITDA | -39.39M | -67.56M | -72.89M | -113.28M | -77.68M |
| EPS Basic | -0.23 | -1.11 | -1.18 | -1.21 | -0.57 |
| Normalized Basic EPS | -0.55 | -0.81 | -0.82 | -1.18 | -0.78 |
| EPS Diluted | -0.24 | -1.11 | -1.19 | -1.22 | -0.58 |
| Normalized Diluted EPS | -0.55 | -0.81 | -0.82 | -1.18 | -0.78 |
| Average Basic Shares Outstanding | 253.56M | 253.10M | 252.62M | 252.12M | 251.63M |
| Average Diluted Shares Outstanding | 253.61M | 253.15M | 252.67M | 252.17M | 251.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |